Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 0.6540
+0.0030 (0.46%)
Nov 12, 2026, 9:30 AM CET
Advicenne Revenue
Advicenne had revenue of 3.70M EUR in the half year ending June 30, 2026, with 40.11% growth. In the year 2025, Advicenne had annual revenue of 7.11M with 24.16% growth. That makes Advicenne the 36,593rd largest company in the world by revenue and 468th in France.
Revenue
7.11M
Revenue Growth
+24.16%
P/S Ratio
0.88
Revenue / Employee
976.09K
Employees
11
Market Cap
9.51M
Revenue by Geography
- European Union 5.59M 96.5%
- Rest of The World 203.00K 3.5%
Fiscal year ended Dec 31, 2025 See the full Advicenne breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.11M | 1.38M | 24.16% |
| Dec 31, 2024 | 5.73M | 2.24M | 64.37% |
| Dec 31, 2023 | 3.48M | 475.00K | 15.79% |
| Dec 31, 2022 | 3.01M | -759.00K | -20.15% |
| Dec 31, 2021 | 3.77M | 202.00K | 5.67% |
| Dec 31, 2020 | 3.57M | 981.00K | 37.96% |
| Dec 31, 2019 | 2.58M | -4.34M | -62.68% |
| Dec 31, 2018 | 6.92M | 4.35M | 169.21% |
| Dec 31, 2017 | 2.57M | 679.00K | 35.87% |
| Dec 31, 2016 | 1.89M | 1.08M | 132.27% |
| Dec 31, 2015 | 815.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 24.58M |
| Poxel | 7.66M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.80M |
| Plant Advanced Technologies | 1.56M |
| Aton | 602.00K |
| NFL Biosciences | 3.15K |
| Quantum Genomics Société Anonyme | 10.00 |